ReviewEco-Environment & Health2022
SARS-CoV-2 aerosol transmission and detection.
Review in Eco-Environment & Health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 22 citations in OpenAlex.
- AI-guided multi-omics analysis identifies NPC1-modulated susceptibility to SARS-CoV-2 infection under PMNature communications · 2026Article
- Antiviral Surface Coatings: From Pandemic Lessons to Visible-Light-Activated Films.Materials (Basel, Switzerland) · 2025Review
- Bioaerosol Inactivation by a Cold Plasma Ionizer Coupled with an Electrostatic Precipitator.Microorganisms · 2024Article
- Laboratory studies on the infectivity of human respiratory viruses: Experimental conditions, detections, and resistance to the atmospheric environment.Fundamental research · 2024Review
- An overview for monitoring and prediction of pathogenic microorganisms in the atmosphere.Fundamental research · 2024Review
- Decay pattern of SARS-CoV-2 RNA surface contamination in real residences.Scientific reports · 2024Article
- The distribution characteristics of aerosol bacteria in different types of sheepfolds.Frontiers in veterinary science · 2024Article
- Space and social distancing in managing and preventing COVID-19 community spread: An overview.Heliyon · 2023Article
- SARS-CoV-2 in Atmospheric Particulate Matter: An Experimental Survey in the Province of Venice in Northern Italy.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aerosol transmission has been officially recognized by the world health authority resulting from its overwhelming experimental and epidemiological evidences. Despite substantial progress, few additional actions were taken to prevent aerosol transmission, and many key scientific questions still await urgent investigations. The grand challenge, the effective control of aerosol transmission of COVID-19, remains unsolved. A better understanding of the viral shedding into the air has been developed, but its temporal pattern is largely unknown. Sampling tools, as one of the critical elements for studying SARS-CoV-2 aerosol, are not readily available around the world. Many of them are less capable of preserving the viability of SARS-CoV-2, thus offering no clues about viral aerosol infectivity. As evidenced, the viability of SARS-CoV-2 is also directly impacted by temperature, humidity, sunlight, and air pollutants. For SARS-CoV-2 aerosol detection, liquid samplers, together with real-time polymerase chain reaction (RT-PCR), are currently used in certain enclosed or semi-enclosed environments. Sensitive and rapid COVID-19 screening technologies are in great need. Among others, the breath-borne-based method emerges with global attention due to its advantages in sample collection and early disease detection. To collectively confront these challenges, scientists from different fields around the world need to fight together for the welfare of mankind. This review summarized the current understanding of the aerosol transmission of SARS-CoV-2 and identified the key knowledge gaps with a to-do list. This review also serves as a call for efforts to develop technologies to better protect the people in a forthcoming reopening world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.